Networking +
Policy +
Member
Career
Choose
Weekly Policy Update: Senate Finance Committee Advances Drug Pricing Package
By: Colorado BioScience Association Date: 07/26/2019
On Thursday, the Senate Finance Committee advanced a major legislative package that includes substantial changes to Medicare and Medicaid drug reimbursement. The bill, the Prescription Drug Pricing Re...
Learn More2019 Rocky Mountain Life Science Investor and Partnering Conference Opens in Vail
By: Colorado BioScience Association Date: 07/24/2019
Colorado BioScience Association connects health innovators to investors during biennial event Vail, Colo. – Colorado BioScience Association (CBSA) welcomes investors and strategic partners from across...
Learn MoreWeekly Policy Update: We Work For Health Summit—CBSA Urges Federal Lawmakers to Promote Medical Innovation and Protect Patient Access
By: Colorado BioScience Association Date: 07/22/2019
This week CBSA vice president Emily Roberts joined other state advocates in Washington, DC for the We Work For Health Summit. During the two-day event, advocates met with their respective delegation t...
Learn MoreViewray to Expand to Denver, Adding 274 Jobs
By: Colorado BioScience Association Date: 07/16/2019
Viewray, Inc., an Ohio-based medical technology company that provides high-level MRI-guided radiation technology is expanding its operations in the metro Denver area and will be hiring 274 people over...
Learn MoreWeekly Policy Update: Trump Administration Pulls Rebate Rule
By: Colorado BioScience Association Date: 07/15/2019
Last week the Trump Administration withdrew their proposed rebate rule that would have required manufacturer rebates to be passed through to patients in Part D and other government programs. The propo...
Learn MoreWeekly Policy Update: Drug Pricing Bills Pass Key Senate Committees
By: Colorado BioScience Association Date: 07/08/2019
Before the holiday, both the Senate Judiciary Committee and the Senate Health, Education, Labor, and Pensions (HELP) Committee advanced legislative packages aimed at lowering prescription drug prices....
Learn MoreWeekly Policy Update: New Economic Forecast Indicates Increase in Expected Revenue Above the TABOR Cap
By: Colorado BioScience Association Date: 06/20/2019
The Colorado Legislative Council released their updated budget and economic forecast this week, which showed a strong economy in the state of Colorado, an increase in expected revenue, and high wage g...
Learn MoreNew State-of-the-Art Facility Increases Agilent's Capacity to Produce Nucleic Acid-Based Therapeutics
By: Colorado BioScience Association Date: 06/18/2019
New facility in Frederick, Colorado, to produce high-quality molecules with the potential to treat cancer and other diseases SANTA CLARA, Calif., June 18, 2019 Agilent Technologies Inc. (NYSE: A) toda...
Learn MorePfizer to buy Colorado's Array BioPharma in deal worth $11.4 billion
By: Colorado BioScience Association Date: 06/17/2019
Pharmaceutical giant Pfizer Inc. is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma Inc., a Colorado drug developer that has seen its shares soar since announ...
Learn MoreWeekly Policy Update: CBSA Submits Comment Letter to Senate Finance Committee’s Health Task Force Urging Repeal of the Medical Device Excise Tax
By: Colorado BioScience Association Date: 06/14/2019
Last month, leaders of the Senate Finance Committee announced the formation of several bipartisan task forces to examine 42 temporary tax provisions that expired or will expire between December 31, 20...
Learn More